Estrella Immunopharma Inc. Warrant. Replay the stock market charts of ESLAW day by day, back to 2003. Open long and short positions without spending any money. Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company is headquartered in EmeryVille, California.